Healthcare
OncoOne – SUCCESS PAGE – December 3, 2024
The world-class antibody engineers at OncoOne are creating monoclonal antibodies to treat diseases with exacting specificity and precision
The world-class antibody engineers at OncoOne are creating monoclonal antibodies to treat diseases with exacting specificity and precision
First-in-industry devices to optimize cancer therapies and address infectious disease disorders that are not treatable with drugs
The world-class antibody engineers at OncoOne are creating monoclonal antibodies to treat diseases with exacting specificity and precision
Direct Biologics is a clinical-stage biotech innovator that is harnessing signaling molecules to reduce overactive inflammatory response
Direct Biologics is a clinical-stage biotech innovator that is harnessing signaling molecules to reduce overactive inflammatory response
D-ID’s AI-powered digital video platform seamlessly transforms images, text, videos, audio, and voice into highly engaging Digital People
D-ID’s AI-powered digital video platform seamlessly transforms images, text, videos, audio, and voice into highly engaging Digital People
An innovative, clinical stage, drug development company that is creating a potential novel treatment for degenerative eye disease
Element Fleet has a developed a new securitized trust that has the potential to deliver significant tax advantages
The company’s AI-powered drug development program has the potential to treat multiple CNS diseases and impact millions of lives.
Ceresti’s Caregiver-Enabled Dementia Program is a tech-powered approach to dementia care that reduces the total cost of care by more than 30%
An innovative, clinical stage, drug development company that is creating a potential novel treatment for degenerative eye disease